Krishna Institute of Medical Sciences raises ₹1,500 crore via QIP at ₹755 per share
The QIP opened on 16 June 2026 and closed on 19 June 2026, with allotment at ₹755 per share. The transaction increases paid-up equity capital from ₹8,002.78 lakh to ₹8,400.01 lakh, representing 4.73% dilution to pre-issue shareholders. Board approval was granted on 11 March 2026, followed by shareholder postal ballot clearance on 15 April 2026. Proceeds will be deployed primarily toward repayment of outstanding borrowings (estimated ₹1,000 cr per management guidance) and subsidiary capitalisation, supporting organic growth across Telangana, Andhra Pradesh, Karnataka, Kerala, and Maharashtra, where KIMS operates 26 hospitals with 7,300+ beds.
Why it mattersQIP pricing at ₹755 (below the ₹771.73 floor price, representing a 2.17% discount) reflects strong institutional appetite despite new-unit EBITDA erosion; the debt-reduction focus signals management prioritisation of balance-sheet stability over aggressive capex, a disciplined approach in a high-leverage expansion phase.
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- Bar & Bench (Deal Street)
- Legal Era Online
- ScanX Trade
- Screener.in
- Business Standard
- The Globe and Mail (TipRanks Syndication)
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026